Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LECANEMAB-IRMB vs LEMBOREXANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LECANEMAB-IRMB vs LEMBOREXANT: Safety Overview

Metric LECANEMAB-IRMB LEMBOREXANT
Total FAERS Reports 2,469 989
Deaths Reported 82 44
Death Rate 3.3% 4.4%
Hospitalizations 474 278
Average Patient Age 74.1 yrs 58.9 yrs
% Female Patients 58.6% 63.4%
FDA Approval Date N/A Apr 7, 2020
Manufacturer Eisai Inc. Eisai Inc.
Route N/A ORAL
Marketing Status Prescription Prescription